Figure 3

Comparison of clinical end point of liver fat reduction, (a) % change from baseline in MRI-PDFF; (b) SomaSignal panel derived end point of liver fat reduction, % change from baseline in steatosis probability score (n = 72, Wilcoxon signed-rank test).